RUBY MANGSATABAM: Open Payments
NPI 1215379326 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 16 payments from 5 companies in 2025. Trend: 2023 $391 · 2024 $403 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $159 |
| ABBVIE INC. | 4 | $69 |
| Alkermes, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: INVEGA SUSTENNA, VRAYLAR, ARISTADA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
